NASDAQ: TVTX · Biotechnology
Over the past week, Travere Therapeutics (TVTX) pulled in 11 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 7% bullish but is deeply split: News runs 22% bullish while X sits at just 0%. Wall Street is more constructive, with 14 of 15 analysts rating TVTX a buy.
There is little buzz around TVTX this week and some agreement on direction, which is why it reads as a Sell.
Wall Street’s 93% buy share sits next to a crowd that ranges from X at 0% to News at 22%. No other tracker puts the two side by side.
Across 15 analysts the consensus is a Strong Buy: 14 buy calls against 0 sell, with an average 12-month price target of $72.79.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources only partly agree, so the read is a Sell.
Analysts sit 86 points above the crowd average of 7%, the professionals are more constructive than retail. The split is inside the crowd: News reads 22% bullish while X sits at 0%, a 22-point spread that single-source trackers miss.
Over the 30-day window, Travere Therapeutics (TVTX) buzz held subdued around 14.0 while the price drifted up 9.6% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.7M shares. Updated Aug 15, 2026. Over the last 7 trading days, TVTX held roughly flat. Buzz activity in the recent week averaged 26.0 and was variable, swinging between 14.0 and 41.8. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 5 of the 14 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for TVTX and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live TVTX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (14 / 1 / 0) |
| Crowd bullish (7d) | 7% |
| Avg price target | $72.79 |
| Most bullish source | News, 22% |
| Most bearish source | X, 0% |
| Sentiment spread | 22 pts |
| Mentions (7d) | 11 |
| Market cap | $5.86B |
| P/E · Forward P/E | n/a · 76.3 |
| EPS · Beta | -$0.74 · 1.0 |
| Revenue (TTM) | $591.3M · -7% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Travere Therapeutics (TVTX) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 7% bullish across 3 active sources. Those sources contribute 11 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Travere Therapeutics (TVTX) is fairly quiet with 0 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Travere Therapeutics (TVTX), averaging 7% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 22% bullish and X at 0%, a 22-point spread. On the professional side, 14 of 15 analysts rate TVTX a buy.
Of the 15 analysts covering Travere Therapeutics (TVTX), 14 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $72.79. That puts the street ahead of the crowd, which averages 7% bullish.
Travere Therapeutics (TVTX)'s cross-source average is bearish at 7% bullish. All 3 tracked sources lean bearish. X reads 0% bullish, News reads 22% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Travere Therapeutics (TVTX) at 7% bullish. All 3 tracked sources lean bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is falling across News. The sell signal carries 93/100 conviction.
News is the dominant discussion channel with 9 mentions (82% of total volume). X contributes 2 mentions. The cross-source average is bearish at 7% bullish. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. TVTX's sell signal at 93/100 conviction reflects a bearish cross-source average at 7% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The TVTX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key